Research map: Genomic correlates of clinical CAR T cell activity

Back to the article

Papers in this map

  1. Fast and accurate short read alignment with Burrows–Wheeler transform · Heng Li · 2009 · 64044 citations · Cited by this paper
  2. Copper supports regulatory T cell energetic state to sustain peripheral immune tolerance · 2026 · Related
  3. Matplotlib: A 2D Graphics Environment · John D. Hunter · 2007 · 41200 citations · Cited by this paper
  4. Citraconate preserves T cell stemness and antitumor immunity · 2026 · Related
  5. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Sue M. Richards · 2015 · 33500 citations · Cited by this paper
  6. A breath of fresh AIR in novel CAR T cell design · 2026 · Related
  7. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data · Aaron McKenna · 2010 · 30730 citations · Cited by this paper
  8. The rise of spatial TCR profiling: Emerging technologies and open challenges · 2026 · Related
  9. A global reference for human genetic variation · Corresponding authors · 2015 · 20479 citations · Cited by this paper
  10. Memories that endure · 2026 · Related
  11. Integrative genomics viewer · James Theodore Robinson · 2011 · 17000 citations · Cited by this paper
  12. The epitope tax: Antibody feedback and the economics of germinal center competition · 2026 · Related
  13. A method and server for predicting damaging missense mutations · Ivan A. Adzhubei · 2010 · 13768 citations · Cited by this paper
  14. Palmitate-induced mitochondrial damage restricts histone acetylation in CD8 T cells to impair antitumor immunity · 2026 · Related
  15. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm · P. Naresh Kumar · 2009 · 6820 citations · Cited by this paper
  16. Celebrating a decade of progress at Science Immunology · 2026 · Related
  17. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma · Sattva Swarup Neelapu · 2017 · 6103 citations · Cited by this paper
  18. Gastrointestinal tuft cells: Recent insights and next questions · 2026 · Related
  19. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia · Shannon L. Maude · 2018 · 5822 citations · Cited by this paper
  20. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification · Bruce D. Cheson · 2014 · 5729 citations · Cited by this paper
  21. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma · Stephen J. Schuster · 2018 · 4159 citations · Cited by this paper
  22. Cytokine Storm · David C. Fajgenbaum · 2020 · 3279 citations · Cited by this paper
  23. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study · Jeremy S Abramson · 2020 · 2423 citations · Cited by this paper
  24. Accurate proteome-wide missense variant effect prediction with AlphaMissense · Jun Cheng · 2023 · 2246 citations · Cited by this paper
  25. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma · Michael Wang · 2020 · 1874 citations · Cited by this paper
  26. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma · Noopur S Raje · 2019 · 1781 citations · Cited by this paper
  27. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia · David Porter · 2015 · 1757 citations · Cited by this paper
  28. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma · Frederick Lundry Locke · 2021 · 1610 citations · Cited by this paper
  29. Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells · Juliane Gust · 2017 · 1402 citations · Cited by this paper
  30. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies · C. Dong · 2014 · 1208 citations · Cited by this paper
  31. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target · Robert T. Manguso · 2017 · 1189 citations · Cited by this paper
  32. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy · Emma C. Morris · 2021 · 1120 citations · Cited by this paper
  33. Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia · Bianca Santomasso · 2018 · 954 citations · Cited by this paper
  34. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity · Karthik A. Jagadeesh · 2016 · 935 citations · Cited by this paper
  35. Three-dimensional structure of the neuronal-Sec1–syntaxin 1a complex · Kira M. S. Misura · 2000 · 804 citations · Cited by this paper
  36. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants · Aziz Belkadi · 2015 · 669 citations · Cited by this paper
  37. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial · Caron Alyce Jacobson · 2021 · 664 citations · Cited by this paper
  38. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH · Kejian Zhang · 2011 · 430 citations · Cited by this paper
  39. How I treat hemophagocytic lymphohistiocytosis in the adult patient · Alison M. Schram · 2015 · 421 citations · Cited by this paper

Source: OpenAlex (CC0)